General Information of This Metabolic Reaction (MR) (ID:
MR002503) |
Formula |
|
Reactant |
Vandetanib |
Product |
Vandetanib N-oxide |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Dimethylaniline oxidase 1 (FMO1)
|
DME Info
|
Dimethylaniline oxidase 3 (FMO3)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Pharmacokinetics of vandetanib: three phase I studies in healthy subjects Clin Ther. 2012 Jan;34(1):221-37. doi: 10.1016/j.clinthera.2011.11.011.
|
2 |
Functional evaluation of vandetanib metabolism by CYP3A4 variants and potential drug interactions in vitro Chem Biol Interact. 2021 Dec 1;350:109700. doi: 10.1016/j.cbi.2021.109700.
|
3 |
Identification of Human Enzymes Oxidizing the Anti-Thyroid-Cancer Drug Vandetanib and Explanation of the High Efficiency of Cytochrome P450 3A4 in its Oxidation Int J Mol Sci. 2019 Jul 10;20(14):3392. doi: 10.3390/ijms20143392.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.